Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6

OBJECTIVE: Optimal targeted treatment in rheumatoid arthritis requires early identification of failure to respond. This post hoc analysis explored the relationship between early disease activity changes and the achievement of low disease activity (LDA) and remission targets with tofacitinib. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F., Lee, Eun Bong, Fallon, Lara, Zwillich, Samuel H., Wilkinson, Bethanie, Chapman, Douglass, DeMasi, Ryan, Keystone, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590136/
https://www.ncbi.nlm.nih.gov/pubmed/29696833
http://dx.doi.org/10.1002/acr.23585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590136/
https://www.ncbi.nlm.nih.gov/pubmed/29696833
http://dx.doi.org/10.1002/acr.23585

Ejemplares similares